FRA:PHI1 - NL0000009538 - Common Stock
The current stock price of PHI1.DE is 23.57 EUR. In the past month the price increased by 2.03%. In the past year, price decreased by -13.19%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABL.DE | ABBOTT LABORATORIES | 26.96 | 197.05B | ||
IUI1.DE | INTUITIVE SURGICAL INC | 58.61 | 144.75B | ||
BSX.DE | BOSTON SCIENTIFIC CORP | 37.27 | 133.65B | ||
2M6.DE | MEDTRONIC PLC | 16.58 | 100.69B | ||
SHL.DE | SIEMENS HEALTHINEERS AG | 19.92 | 53.47B | ||
BOX.DE | BECTON DICKINSON AND CO | 13.79 | 48.31B | ||
EWL.DE | EDWARDS LIFESCIENCES CORP | 31.45 | 40.62B | ||
DC4.DE | DEXCOM INC | 44.63 | 25.55B | ||
PHIA.AS | KONINKLIJKE PHILIPS NV | 16.38 | 22.71B | ||
QS51.DE | STRAUMANN HOLDING AG-REG | 35.5 | 15.96B | ||
PHBN.DE | SONOVA HOLDING AG-REG | 25.67 | 14.82B | ||
1SOON.MI | SONOVA HOLDING AG-REG | 24.79 | 14.31B |
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. The company is headquartered in Eindhoven, Noord-Brabant and currently employs 67,823 full-time employees. The company went IPO on 2009-09-18. The firm's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.
KONINKLIJKE PHILIPS NV
High Tech Campus 5
Eindhoven NOORD-BRABANT NL
Employees: 67823
Phone: 31205977777
The current stock price of PHI1.DE is 23.57 EUR. The price decreased by -1.17% in the last trading session.
The exchange symbol of KONINKLIJKE PHILIPS NV is PHI1 and it is listed on the Deutsche Boerse Ag exchange.
PHI1.DE stock is listed on the Deutsche Boerse Ag exchange.
26 analysts have analysed PHI1.DE and the average price target is 27.4 EUR. This implies a price increase of 16.24% is expected in the next year compared to the current price of 23.57. Check the KONINKLIJKE PHILIPS NV stock analysts ratings, price target forecast and up-and down grades for more detailed information.
KONINKLIJKE PHILIPS NV (PHI1.DE) has a market capitalization of 22.70B EUR. This makes PHI1.DE a Large Cap stock.
KONINKLIJKE PHILIPS NV (PHI1.DE) currently has 67823 employees.
KONINKLIJKE PHILIPS NV (PHI1.DE) has a support level at 20.33 and a resistance level at 23.75. Check the full technical report for a detailed analysis of PHI1.DE support and resistance levels.
The Revenue of KONINKLIJKE PHILIPS NV (PHI1.DE) is expected to decline by -1.51% in the next year. Check the estimates tab for more information on the PHI1.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
PHI1.DE does not pay a dividend.
KONINKLIJKE PHILIPS NV (PHI1.DE) will report earnings on 2025-11-04.
The PE ratio for KONINKLIJKE PHILIPS NV (PHI1.DE) is 16.37. This is based on the reported non-GAAP earnings per share of 1.44 and the current share price of 23.57 EUR. Check the full fundamental report for a full analysis of the valuation metrics for PHI1.DE.
ChartMill assigns a technical rating of 7 / 10 to PHI1.DE. When comparing the yearly performance of all stocks, PHI1.DE is a bad performer in the overall market: 62.42% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to PHI1.DE. PHI1.DE may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months PHI1.DE reported a non-GAAP Earnings per Share(EPS) of 1.44. The EPS increased by 11.17% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 0.91% | ||
ROA | 0.61% | ||
ROE | 1.56% | ||
Debt/Equity | 0.69 |
26 analysts have analysed PHI1.DE and the average price target is 27.4 EUR. This implies a price increase of 16.24% is expected in the next year compared to the current price of 23.57.
For the next year, analysts expect an EPS growth of 1.18% and a revenue growth -1.51% for PHI1.DE